Previous 10 | Next 10 |
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that management will be participating in the 7th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference being held August 15-16, 2022. Management will host one-on-one vi...
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that the Chinese National Intellectual Property Administration has issued two new patents to ENDRA, Chinese Patent No. ZL 2020 8 00151255 (the ‘255 pat...
ENDRA Life Sciences (NASDAQ:NDRA) is trading 10% higher premarket after the United States Patent and Trademark Office issued a new patent for its Taeus’ radiofrequency (RF) applicator for optimizing the delivery of RF energy to tissue. Thermo-Acoustic Enhanced Ultra...
ENDRA Life Sciences Inc. (NASDAQ: NDRA) , a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that the United States Patent and Trademark Office has issued a new ENDRA patent, U.S. Patent No. 11369272 (the ‘272 patent) titled “Broadband ...
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that management will be participating in the JMP Securities Life Sciences Conference being held June 15-16, 2022 in New York City. Management will present a company overview on We...
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announces that the United States Patent & Trademark Office has issued a new patent to ENDRA, U.S. Patent No. 11337676 (the ‘676 patent) titled “Acoust...
3 Penny Stocks That Investors Are Buying in May 2022 With May proving to be another interesting month for penny stocks and blue chips, there is a lot that investors need to keep track of. First and foremost, we know that penny stocks are in an extremely volatile place right now. Thi...
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, announces that management will present a company overview at the H.C. Wainwright Global Investment Conference being held May 23-26, 2022 in Miami Beach and will be holding virtual one-on-one meet...
ENDRA Life Sciences Inc. (NDRA) Q1 2022 Earnings Conference Call May 12, 2022, 04:30 PM ET Company Participants Yvonne Briggs - IR Francois Michelon - Chairman and CEO Mike Thornton - Chief Technology Officer Renaud Maloberti - CCO Irina Pestrikova - Senior Director, Finance Conference Call P...
Endra Life Sciences press release (NASDAQ:NDRA): Q1 GAAP EPS of -$0.07. Cash and cash equivalents were $7.1 million as of March 31, 2022; $7.8 million was raised subsequent to the close of the first quarter through the company’s ATM facility. For further details see: Endra Life S...
News, Short Squeeze, Breakout and More Instantly...
ENDRA Life Sciences Inc. Company Name:
NDRA Stock Symbol:
NASDAQ Market:
ENDRA Life Sciences Inc. Website:
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), today announced that the company will report financial results for the three months ended March 31, 2023 on Monday, May 15, 2023 after the close of trading on the U.S. financia...
ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announced today the closing of its previously announced underwritten public offering of 4,312,500 shares of its common stock and ...
ENDRA Life Sciences Inc. (Nasdaq: NDRA) (“ENDRA” or the “Company”), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS ® ), announced today that it has priced an underwritten public offering of 3,750,000 shares of its common stock and warrants to purcha...